{"filing":{"accession_number":"0001213900-26-093379","cik":"0001840425","ticker":"OSRHW","company_name":"OSR Health, Inc.","form":"8-K","filing_date":"2026-08-25","report_date":"2026-08-25","primary_document":"ea0303318-8k_osrhealth.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1840425/000121390026093379/ea0303318-8k_osrhealth.htm"},"events":[{"id":29389,"run_id":26907,"accession_number":"0001213900-26-093379","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"OSR Health disclosed a Staff Determination Letter from Nasdaq notifying the company of its determination to delist the company's common stock and warrants for non-compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company submitted a timely hearing request on August 25, 2026, which will stay formal delisting pending the Panel's decision, but trading suspension is scheduled for August 26, 2026. This is a clear delisting risk disclosure under Item 8.01, materially affecting investor assessment of the registrant's continued listing status.","company_name":"OSR Health, Inc.","ticker":"OSRHW","filing_date":"2026-08-25","form":"8-K","submitted_at":null,"items":[{"id":31658,"accession_number":"0001213900-26-093379","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"OSR Health disclosed a Staff Determination Letter from Nasdaq notifying the company of its determination to delist the company's common stock and warrants for non-compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company submitted a timely hearing request on August 25, 2026, which will stay formal delisting pending the Panel's decision, but trading suspension is scheduled for August 26, 2026. This is a clear delisting risk disclosure under Item 8.01, materially affecting investor assessment of the registrant's continued listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-25T15:29:36.909895+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":31658,"accession_number":"0001213900-26-093379","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"OSR Health disclosed a Staff Determination Letter from Nasdaq notifying the company of its determination to delist the company's common stock and warrants for non-compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company submitted a timely hearing request on August 25, 2026, which will stay formal delisting pending the Panel's decision, but trading suspension is scheduled for August 26, 2026. This is a clear delisting risk disclosure under Item 8.01, materially affecting investor assessment of the registrant's continued listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-25T15:29:36.909895+00:00","company_name":"OSR Health, Inc.","ticker":"OSRHW","filing_date":"2026-08-25"}]}